Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion

International Journal of Oncology

Volumn 28, Issue 4, 2006, Pages 847-854

  Ding, Yi ^a,b   Wang, Gang ^a,b   Ling, Ming Tat ^a   Wong, Y C ^a   Li, Xin ^a,b   Na, Yanqun ^b   Zhang, Xiaomeng ^a   Chua, Chee Wai ^a   Wang, Xianghong ^a   Xin, Dianqi ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Bladder cancer; Epidermal growth factor receptor; Inhibitor of differentiation DNA binding; Invasion

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; ID1 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 1; LUCIFERASE; SMALL INTERFERING RNA;

ARTICLE; BLADDER TUMOR; CANCER INVASION; CANCER STAGING; CELL MOTION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; RNA INTERFERENCE; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; LUCIFERASES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROMOTER REGIONS (GENETICS); RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 33744758656     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.4.847     Document Type: Article

References (36)

1. Fitzpatrick JM, West AB, Butler MR, Lane V and O'Flynn JD: Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol 135: 920-922, 1986.
2. Pearse HD, Reed RR and Hodges CV: Radical cystectomy for bladder cancer. J Urol 119: 216-218, 1978.
3. Gospodarowicz MK, Hawkins NV, Rawlings GA, Connolly JG, et al: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142: 1448-1453, 1989.
4. Winquist E, Kirchner TS, Segal R, Chin J and Lukka H: Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. J Urol 171: 561-569, 2004.
5. Colquhoun AJ and Mellon JK: Epidermal growth factor receptor and bladder cancer. Postgrad Med J 78: 584-589, 2002.
6. Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JR and Harris AL: Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet 1: 366-368, 1985.
7. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR and Harris AL: The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65: 1619-1625, 1990. (Pubitemid 20106125)
8. Mellon K, Wright C, Kelly P, Horne CH and Neal DE: Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol 153: 919-925, 1995.
9. Chow NH, Liu HS, Lee EI, Chang CJ, Chan SH, Cheng HL, Tzai TS and Lin JS: Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res 17: 1293-1296, 1997.
10. Nguyen PL, Swanson PE, Jaszcz W, Aeppli DM, Zhang G, Singleton TP, Ward S, Dykoski D, Harvey J and Niehans GA: Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am J Clin Pathol 101: 166-176, 1994. (Pubitemid 24061443)
11. Cheng J, Huang H, Zhang ZT, Shapiro E, Pellicer A, Sun TT and Wu XR: Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res 62: 4157-4163, 2002. (Pubitemid 34791088)
12. Schafer B, Gschwind A and Ullrich A: Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23: 991-999, 2004. (Pubitemid 38250945)
13. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997. (Pubitemid 27371946)
14. Maddineni SB, Sangar VK, Hendry JH, Margison GP and Clarke NW: Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines. Br J Cancer 92: 125-130, 2005.
15. Ling MT, Wang X, Lee DT, Tam PC, Tsao SW and Wong YC: Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Carcinogenesis 25: 517-525, 2004. (Pubitemid 38499942)
16. Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H: The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49-59, 1990.
17. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J and Desprez PY: A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60: 1332-1340, 2000.
18. Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA and Korc M: Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 155: 815-822, 1999.
19. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B and Birner P: Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 61: 5703-5706, 2001.
20. Langlands K, Down GA and Kealey T: Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res 60: 5929-5933, 2000.
21. Ouyang XS, Wang X, Lee DT, Tsao SW and Wong YC: Overexpression of ID-1 in prostate cancer. J Urol 167: 2598-2602, 2002.
22. Schindl M, Schoppmann SF, Strobel T, Heinzl H, Leisser C, Horvat R and Birner P: Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res 9: 779-785, 2003.
23. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ and Desprez PY: Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci USA 100: 13543-13548, 2003.
24. Ling MT, Wang X, Ouyang XS, Lee TK, Fan TY, Xu K, Tsao SW and Wong YC: Activation of MAPK signaling pathway is essential for Id-1 induced serum-independent prostate cancer cell growth. Oncogene 21: 8498-8505, 2002. (Pubitemid 36054890)
25. Ouyang XS, Wang X, Ling MT, Wong HL, Tsao SW and Wong YC: Id-1 stimulates serum-independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis 23: 721-725, 2002. (Pubitemid 34567509)
26. Zhang X, Ling MT, Feng H, Wong YC, Tsao SW and Wang X: Id-I stimulates cell proliferation through activation of EGFR in ovarian cancer cells. Br J Cancer 91: 2042-2047, 2004. (Pubitemid 40128771)
27. Chun Z: M-TLTK-WLKMXWaY-CW. FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase. Cancer Lett 2005.
28. Lo AK, Liu Y, Wang XH, Huang DP, Yuen PW, Wong YC and Tsao GS: Alterations of biologic properties and gene expression in nasopharyngeal epithelial cells by the Epstein-Barr virus-encoded latent membrane protein 1. Lab Invest 83: 697-709, 2003.
29. Bue P, Wester K, Sjostrom A, Holmberg A, Nilsson S, Carlsson J, Westlin JE, Busch C and Malmstrom PU: Expression of epidermal growth factor receptor in urinary bladder cancer metastases. Int J Cancer 76: 189-193, 1998.
30. Baselga J, Pfister D, Cooper MR, Cohen R, Burtness B, Bos M, D'Andrea G, Seidman A, Norton L, Gunnett K, Falcey J, Anderson V, Waksal H and Mendelsohn J: Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol 18: 904-914, 2000.
31. Wong YC, Wang X and Ling MT: Id-1 expression and cell survival. Apoptosis 9: 279-289, 2004.
32. Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissell MJ and Campisi J: A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 18: 4577-4588, 1998.
33. Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK, Wang X and Wong YC: Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through activation of vascular endothelial growth factor (VEGF). Carcinogenesis (In press).
34. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K and Benezra R: Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670-677, 1999. (Pubitemid 29485206)
35. Herbst RS and Shin DM: Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer 94: 1593-1611, 2002.
36. Albanell J, Rojo F and Baselga J: Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839. Semin Oncol 28: 56-66, 2001.